Journal of Biomaterials Science Polymer Edition · 2014 · 22 citations · 23 references
EngineeringBioengineeringBiomedical EngineeringRegenerative MedicineTissue EngineeringWound HealingBiologic Skin SubstitutesDermal TissueExtracellular Matrix DepositionSkin RegenerationSkin Tissue EngineeringWound Healing BiomaterialsArtificial Skin SubstitutesCulture Medium FormulationFibroblast-containing Skin SubstitutesHyaluronic Acid BiomaterialsHyaluronic Acid-based Skin SubstitutesSerum-free CultureSerum-free MediaVascular Endothelial Growth Factor
The present study aimed to develop a two-layered cultured dermal substitute (CDS). The upper layer is a hyaluronic acid (HA) and collagen (Col) spongy sheet with or without epidermal growth factor (EGF). The lower layer is a HA spongy sheet and Col gel containing fibroblasts. The CDS is prepared in serum-free medium, followed by placing on the wound surface. Corresponding to clinical application, CDS was incubated in serum-free medium for a period of 1, 3 or 5 days, followed by placing onto the air and culture medium interface (wound surface model), and culture for 6 days using conventional culture medium supplemented with serum. Metabolic activity and cytokine production were considerably higher in EGF-incorporating CDS, as compared with EGF-free CDS. Metabolic activity of EGF-incorporating CDS was maintained for a period of 3 days, but decreased slightly after 5 days. EGF-incorporating CDS is able to effectively stimulate fibroblasts within CDS to release increased amounts of vascular endothelial growth factor and hepatocyte growth factor, which are essential for wound healing. CDS is promising for wound therapy, because there is no risk of cellular damage caused by cryopreservation, thawing and rinsing processes. The critical issue is how to reduce the cellular damage during a prolonged period of incubation in serum-free medium. EGF-incorporating CDS can be used after a period of 3-5 days incubation in serum-free medium. This period is sufficient for transport of CDS from manufacturing facilities to hospitals.
23
Angiogenesis Induced by Degradation Products of Hyaluronic Acid
David C. West, Ian Hampson, Frank Arnold et al. · Science · 1985 · 1.1K citations
Dorit Shweiki, Michal Neeman, Ahuva Itin et al. · Proceedings of the National Academy of Sciences · 1995 · 601 citations
Medicine, Cancer Biology, Oncology +17